Featured Research

from universities, journals, and other organizations

Optical imaging could create pathway for radiotracers, study finds

Date:
July 6, 2010
Source:
Society of Nuclear Medicine
Summary:
A new study reports on investigative research of a novel optical imaging technique called "Cerenkov luminescence imaging." According to the authors, the technique could lead to the faster and more cost-effective development of radiopharmaceuticals for the diagnosis and treatment of cancer and other conditions.

A study published in the July issue of The Journal of Nuclear Medicine (JNM) reports on investigative research of a novel optical imaging technique called "Cerenkov luminescence imaging (CLI)." According to the authors, the technique could lead to the faster and more cost-effective development of radiopharmaceuticals for the diagnosis and treatment of cancer and other conditions.

Related Articles


"The development of novel multimodality imaging agents and techniques could represent the frontier of research in the field of medical imaging science," said Jan Grimm, M.D., Ph.D., a professor and physician at Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical Center in New York and corresponding author for the study. Grimm explained that his group's work, along with current work from groups at the University of California Davis (Simon Cherry, Ph.D.) and Stanford University (Sanjiv Sam Gambhir, M.D., Ph.D.), may open a new path for optical imaging to move into the clinic.

When light travels through water, its speed decreases. A particle that moves faster than light in water produces a "shock wave" (much like the sonic boom that broke the sound barrier), which emits a visible blue light known as "Cerenkov radiation." The researchers write that their study is among the first to explore Cerenkov radiation's applications for medical imaging using optical imaging techniques.

Optical imaging is a molecular imaging procedure in which light-producing molecules designed to attach to specific cells or molecules are injected into the bloodstream and then detected by an optical imaging device. It usually requires either excitation by an external light source or by a biological process. Cerenkov imaging produces the light from the radioactivity, so no external illumination is needed. Combining optical imaging with nuclear medicine presents a new path for imaging medical isotopes, Grimm said. "It provides optical imaging with an array of approved nuclear tracers already in clinical use today, which can be used immediately, as opposed to fluorescent dyes," he added.

For the study, researchers evaluated several radionuclides for potential use with CLI. Researchers used CLI and positron-emission tomography (PET) imaging to visualize tumor-bearing mice. The results show that CLI visualizes radiotracer uptake in vivo. The resulting decrease of light over time correlates with the radioactive decay of the injected tracer.

An added value of this technique is its ability to image radionuclides that do not emit either positrons or gamma rays -- a current limitation for nuclear imaging modalities. CLI brings to light isotopes that could not be visualized previously. Additionally, optical imaging techniques show promise for endoscopy and surgery because of the ability to visualize tumor lesions, which could provide real-time information to surgeons and help guide operations.

"The benefits of optical imaging are numerous, and we're on a path to realizing them," said Grimm. "We are optimistic that these new techniques will one day be available to physicians as another tool for the diagnosis and treatment of disease."

Authors of the study include: Alessandro Ruggiero, Jan Grimm, Nuclear Medicine Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York; Jason P. Holland, Jason S. Lewis, Radiochemistry Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York; Jason S. Lewis, Jan Grimm, Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York.


Story Source:

The above story is based on materials provided by Society of Nuclear Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. A. Ruggiero, J. P. Holland, J. S. Lewis, J. Grimm. Cerenkov Luminescence Imaging of Medical Isotopes. Journal of Nuclear Medicine, 2010; DOI: 10.2967/jnumed.110.076521

Cite This Page:

Society of Nuclear Medicine. "Optical imaging could create pathway for radiotracers, study finds." ScienceDaily. ScienceDaily, 6 July 2010. <www.sciencedaily.com/releases/2010/07/100701103401.htm>.
Society of Nuclear Medicine. (2010, July 6). Optical imaging could create pathway for radiotracers, study finds. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2010/07/100701103401.htm
Society of Nuclear Medicine. "Optical imaging could create pathway for radiotracers, study finds." ScienceDaily. www.sciencedaily.com/releases/2010/07/100701103401.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins